A 5 YEAR MULTICENTER OPEN LABEL PARALLEL GROUP RANDOMIZED STUDY TO DEMONSTRATE THE SHORT AND LONG TERM SAFETY OF ELIDEL PIMECROLIMUS ASM981 CREAM 1 IN THE TREATMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN INFANTS 3 MONTHS OF AGE